MS

Mitulkumar Sureshbhai Zala

Active Director Director DIN 06882851
DIN 06882851 First appointment May 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since May 2014
Shareholding value •••• Premium profile

About Mitulkumar Sureshbhai Zala

Data last updated:

Mitulkumar Sureshbhai Zala is a Director at Maharshi Pharma Chem Private Limited (since 2014), Director at Androst Biotech India Private Limited (since 2022) and Designated Partner at Androzenica Biopharma Llp (since 2022), and holds 1 more current directorship. The companies operate in Pharma, Life Sciences and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹130 Cr; the largest is Maharshi Pharma Chem Private Limited at ₹68.24 Cr (FY 2023). Earlier, Mitulkumar Sureshbhai Zala was a Director at Apister Lifesciences Private Limited (2017–2018) and Director at Ruja Impex Private Limited (2015–2020).

DIN 06882851
Primary Designation Director
Industry Pharma
First Appointment 21 May 2014
Oldest Company Age 28 yrs
Largest company Maharshi Pharma Chem Private Limited · ₹68.24 Cr (FY 2023)
Combined revenue ₹130 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Maharshi Pharma Chem Private Limited U24230GJ1998PTC034706
Director21 May 20141998₹68.24 Cr (FY 2023)Active
Director07 Jul 20222022₹61.85 Cr (FY 2025)Active
Designated Partner20 Jul 20222022Active
Androst Biotech Private Limited U24246GJ2021PTC124216
Director19 Jul 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apister Lifesciences Private Limited U24304GJ2017PTC097161
Director01 May 20172017₹73.56 Cr (FY 2025)Active
Ruja Impex Private Limited U51909GJ2012PTC073181
Director20 Nov 20152012₹9.63 Cr (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Androst Biotech India Private Limited
Maharshi Pharma Chem Private Limited
Androst Biotech Private Limited
Androzenica Biopharma Llp
Premium access

Shareholding and investment profile for Mitulkumar Sureshbhai Zala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mitulkumar Sureshbhai Zala

Mitulkumar Sureshbhai Zala currently holds 4 directorships: Maharshi Pharma Chem Private Limited (Director, since 21 May 2014, revenue ₹68.24 Cr (FY 2023)); Androst Biotech India Private Limited (Director, since 07 Jul 2022, revenue ₹61.85 Cr (FY 2025)); Androzenica Biopharma Llp (Designated Partner, since 20 Jul 2022); Androst Biotech Private Limited (Director, since 19 Jul 2021).

Mitulkumar Sureshbhai Zala was first appointed on 21 May 2014 as Director at Maharshi Pharma Chem Private Limited. The most recent appointment on record is 20 Jul 2022 at Androzenica Biopharma Llp.

The 2 current companies of Mitulkumar Sureshbhai Zala that report revenue have a combined latest revenue of ₹130 Cr: Maharshi Pharma Chem Private Limited ₹68.24 Cr (FY 2023); Androst Biotech India Private Limited ₹61.85 Cr (FY 2025).

Mitulkumar Sureshbhai Zala held 2 earlier board appointments: Apister Lifesciences Private Limited (Director, 01 May 2017 to 13 Jun 2018); Ruja Impex Private Limited (Director, 20 Nov 2015 to 30 Nov 2020).

The current boards of Mitulkumar Sureshbhai Zala's companies include Aashay Jayantilal Patel (Maharshi Pharma Chem Private Limited), Hemal Naranbhai Patel (Maharshi Pharma Chem Private Limited), Paragkumar Gunvantlal Bhavsar (Maharshi Pharma Chem Private Limited), Pradip Vinubhai Darji (Androst Biotech India Private Limited), Shailendra Mandloi (Androzenica Biopharma Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available